CompletedNot Applicable

Microencapsulated Fish Oil or Conjugated Linoleic Acid in Metabolic Syndrome

Brazil37 participantsStarted 2008-05

Plain-language summary

Our aim was to assess the effects of a hypocaloric diet, including diet fruit jelly with microencapsulated fish oil or conjugated linoleic acid or placebo, on anthropometry, body composition, insulin resistance and lipid profile in women with metabolic syndrome and genotype Pro12Pro in the PPAR gamma 2 gene.

Who can participate

Age range30 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adults women (30-45 years old); * diagnosis of metabolic syndrome, as defined by the International Diabetes Federation; * Pro12Pro genotype in gene PPARγ2. Exclusion Criteria: Participants were excluded if they: * Were allergic to strawberries or fish * Were pregnant or lactating * Took fatty acid supplements * Had undergone bariatric surgery or were being treated nutritionally or pharmacologically for reducing BM, or had taken anti-obesity drugs during the previous three months

What they're measuring

Oxidative stress biomarker

Timeframe: Change from baseline at 12 weeks

Trial details

NCT IDNCT02183922

SponsorUniversidade Federal do Rio de Janeiro

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-01

View on ClinicalTrials.gov More Insulin Resistance trials